Skip Nav Destination
Issues
15 October 2003
ISSN 1078-0432
EISSN 1557-3265
Issue Sections
Minireview
Perspectives
Featured Articles
Clinical Trials
Risk and Prognosis of Central Nervous System Leukemia in Patients with Philadelphia Chromosome-Positive Acute Leukemias Treated with Imatinib Mesylate
Heike Pfeifer; Barbara Wassmann; Wolf-Karsten Hofmann; Martina Komor; Urban Scheuring; Patrick Brück; Anja Binckebanck; Eberhard Schleyer; Nicola Gökbuget; Thomas Wolff; Michael Lübbert; Lothar Leimer; Harald Gschaidmeier; Dieter Hoelzer; Oliver G. Ottmann
Pharmacokinetic Study of Cisplatin and Infusional Etoposide Phosphate in Advanced Breast Cancer with Correlation of Response to Topoisomerase IIα Expression
Jeremy P. Braybrooke; Nicola C. Levitt; Simon Joel; Theresa Davis; Srinivasan Madhusudan; Helen Turley; Sue Wilner; Adrian L. Harris; Denis C. Talbot
Molecular Oncology, Markers, Clinical Correlates
A Training-Testing Approach to the Molecular Classification of Resected Non-Small Cell Lung Cancer
Noboru Yamagata; Yu Shyr; Kiyoshi Yanagisawa; Mary Edgerton; Thao P. Dang; Adriana Gonzalez; Sorena Nadaf; Paul Larsen; John R. Roberts; Jonathan C. Nesbitt; Roy Jensen; Shawn Levy; Jason H. Moore; John D. Minna; David P. Carbone
Relationships between Plasma Insulin-like Growth Factor-I and Insulin-like Growth Factor Binding Protein-3 and Second Breast Cancer Risk in a Prevention Trial of Fenretinide
Andrea Decensi; Umberto Veronesi; Rosalba Miceli; Harriet Johansson; Luigi Mariani; Tiziana Camerini; Maria Gaetana Di Mauro; Elena Cavadini; Giuseppe De Palo; Alberto Costa; Marjorie Perloff; Winfred F. Malone; Franca Formelli
Experimental Therapeutics, Preclinical Pharmacology
ZD1839 (Iressa) Modifies the Activity of Key Enzymes Linked to Fluoropyrimidine Activity: Rational Basis for a New Combination Therapy with Capecitabine
Nicolas Magné; Jean-Louis Fischel; Alain Dubreuil; Patricia Formento; Joseph Ciccolini; Jean-Louis Formento; Céline Tiffon; Nicole Renée; Sandrine Marchetti; Marie-Christine Etienne; Gérard Milano
Regular Articles
Clinical Trials
A Phase I, Pharmacokinetic, and Biological Study of the Farnesyltransferase Inhibitor Tipifarnib in Combination with Gemcitabine in Patients with Advanced Malignancies
Amita Patnaik; S. Gail Eckhardt; Elzbieta Izbicka; Anthony A. Tolcher; Lisa A. Hammond; Chris H. Takimoto; Garry Schwartz; Heather McCreery; Andrew Goetz; Masataka Mori; Kazutoyo Terada; Lou Gentner; Mary-Ellen Rybak; Henry Richards; Steven Zhang; Eric K. Rowinsky
SU5416 Plus Interferon α in Advanced Renal Cell Carcinoma: A Phase II California Cancer Consortium Study with Biological and Imaging Correlates of Angiogenesis Inhibition
Primo N. Lara, Jr.; David I. Quinn; Kim Margolin; Frederick J. Meyers; Jeff Longmate; Paul Frankel; Philip C. Mack; Corinne Turrell; Peter Valk; Jyotsna Rao; Penelope Buckley; Ted Wun; Robert Gosselin; Irina Galvin; Paul H. Gumerlock; Heinz Josef Lenz; James H. Doroshow; David R. Gandara
Cancer Biology, Immunology, Cytokines
Research Articles
Molecular Oncology, Markers, Clinical Correlates
Retention of the p53 Codon 72 Arginine Allele Is Associated with a Reduction of Disease-Free and Overall Survival in Arginine/Proline Heterozygous Breast Cancer Patients
Massimiliano Bonafé; Claudio Ceccarelli; Fulvia Farabegoli; Donatella Santini; Mario Taffurelli; Cristiana Barbi; Erika Marzi; Chiara Trapassi; Gianluca Storci; Fabiola Olivieri; Claudio Franceschi
Molecular Detection of Breast Cancer Cells in the Peripheral Blood of Advanced-Stage Breast Cancer Patients Using Multimarker Real-Time Reverse Transcription-Polymerase Chain Reaction and a Novel Porous Barrier Density Gradient Centrifugation Technology
Megan K. Baker; Kaidi Mikhitarian; Walid Osta; Kathi Callahan; Rana Hoda; Frank Brescia; Rayna Kneuper-Hall; Michael Mitas; David J. Cole; William E. Gillanders
Interleukin 1 System and Sex Steroid Receptor Expression in Human Breast Cancer: Interleukin 1α Protein Secretion Is Correlated with Malignant Phenotype
Christian F. Singer; Nicole Kronsteiner; Gernot Hudelist; Erika Marton; Ingrid Walter; Marion Kubista; Klaus Czerwenka; Martin Schreiber; Michael Seifert; Ernst Kubista
Evaluation of Urinary Plasminogen Activator, Its Receptor, Matrix Metalloproteinase-9, and von Willebrand Factor in Pancreatic Cancer
Shashi R. Harvey; Thelma C. Hurd; Gabor Markus; Maisie I. Martinick; Remedios M. Penetrante; Dongfeng Tan; Preeti Venkataraman; Nisha DeSouza; Sheila N. J. Sait; Deborah L. Driscoll; John F. Gibbs
Experimental Therapeutics, Preclinical Pharmacology
Multidrug-Resistant Tumor Cells Remain Sensitive to a Recombinant Interleukin-4-Pseudomonas Exotoxin, Except When Overexpressing the Multidrug Resistance Protein MRP1
Mariska C. de Jong; George L. Scheffer; Henk J. Broxterman; Jan H. Hooijberg; Jerry W. Slootstra; Rob H. Meloen; Robert J. Kreitman; Syed R. Husain; Bharat H. Joshi; Raj K. Puri; Rik J. Scheper
Correction
Advertisement
